Filtered By:
Vaccination: Whooping Cough (Pertussis) Vaccine
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 1106 results found since Jan 2013.
Bordetella bronchiseptica and Bordetella pertussis: Similarities and Differences in Infection, Immuno-Modulation, and Vaccine Considerations
Clin Microbiol Rev. 2023 Jun 12:e0016422. doi: 10.1128/cmr.00164-22. Online ahead of print.ABSTRACTBordetella pertussis and Bordetella bronchiseptica belong to the genus Bordetella, which comprises 14 other species. B. pertussis is responsible for whooping cough in humans, a severe infection in children and less severe or chronic in adults. These infections are restricted to humans and currently increasing worldwide. B. bronchiseptica is involved in diverse respiratory infections in a wide range of mammals. For instance, the canine infectious respiratory disease complex (CIRDC), characterized by a chronic cough in dogs. At...
Source: Clinical Microbiology Reviews - June 12, 2023 Category: Microbiology Authors: Beatriz Miguelena Chamorro Karelle De Luca Gokul Swaminathan St éphanie Longet Egbert Mundt St éphane Paul Source Type: research
Influenza and pertussis vaccine coverage in pregnancy in Australia, 2016-2021
Med J Aust. 2023 May 29. doi: 10.5694/mja2.51989. Online ahead of print.ABSTRACTVaccination in pregnancy is the best strategy to reduce complications from influenza or pertussis infection in infants who are too young to be protected directly from vaccination. Pregnant women are also at risk of influenza complications preventable through antenatal vaccination. Both vaccines are funded under the National Immunisation Program for pregnant women in Australia, but coverage is not routinely reported nationally. We reviewed all reported Australian maternal influenza and pertussis vaccine coverage data for the period 2016-2021, to...
Source: Med J Aust - May 30, 2023 Category: General Medicine Authors: Jocelynne E McRae Lisa McHugh Catherine King Frank H Beard Christopher C Blyth Margie H Danchin Michelle L Giles Hassen Mohammed Nicholas Wood Kristine Macartney Source Type: research
Estimating global changes in routine childhood vaccination coverage during the COVID-19 pandemic, 2020-2021
CONCLUSION: The COVID-19 pandemic exerted larger disruptions to routine vaccination services in 2021 than in 2020. Global efforts will be needed to recoup vaccine coverage losses sustained during the pandemic and broaden vaccine access in areas where coverage was previously inadequate.PMID:37246068 | PMC:PMC10201316 | DOI:10.1016/j.vaccine.2023.05.034
Source: Vaccine - May 28, 2023 Category: Allergy & Immunology Authors: Cyrus Ghaznavi Akifumi Eguchi Kaung Suu Lwin Daisuke Yoneoka Yuta Tanoue Santosh Kumar Rauniyar Sayaka Horiuchi Masahiro Hashizume Shuhei Nomura Source Type: research
Impact of pregnancy on polyfunctional IgG and memory B cell responses to Tdap immunization
CONCLUSIONS: This study demonstrates that pregnancy does not affect the quality of effector IgG and memory B cell responses to Tdap immunization and that polyfunctional IgG are efficiently transferred across the placenta.REGISTRY'S URL AND THE TRIAL'S REGISTRATION NUMBER: ClinicalTrials.Gov (NCT03519373).PMID:37244810 | DOI:10.1016/j.vaccine.2023.05.035
Source: Vaccine - May 27, 2023 Category: Allergy & Immunology Authors: Martin Taton Fabienne Willems Cyprien Widomski Charlotte Martin Yiwei Jiang Katty Renard Alexandra Cogan Coca Necsoi Margaret E Ackerman Arnaud Marchant Nicolas Dauby Source Type: research
Immune responses and protection against Streptococcus pneumoniae elicited by recombinant Bordetella pertussis adenylate cyclase (CyaA) carrying fragments of pneumococcal surface protein A, PspA
Vaccine. 2023 May 24:S0264-410X(23)00570-4. doi: 10.1016/j.vaccine.2023.05.031. Online ahead of print.ABSTRACTStreptococcus pneumoniae is a common agent of important human diseases such as otitis media, pneumonia, meningitis and sepsis. Current available vaccines that target capsular polysaccharides induce protection against invasive disease and nasopharyngeal colonization in children, yet their efficacy is limited to the serotypes included in the formulations. The virulence factor Pneumococcal Surface Protein A (PspA) interacts with host immune system and helps the bacteria to evade phagocytosis. Due to its essential role...
Source: Vaccine - May 26, 2023 Category: Allergy & Immunology Authors: Giovanna Brito Carneiro Julia Tavares Castro Marilyne Davi Eliane Namie Miyaji Daniel Ladant Maria Leonor Sarno Oliveira Source Type: research
Human papillomavirus vaccination at the first opportunity: An overview
Hum Vaccin Immunother. 2023 May 23:2213603. doi: 10.1080/21645515.2023.2213603. Online ahead of print.ABSTRACTThe Advisory Committee on Immunization Practices (ACIP) has recommended human papillomavirus (HPV) vaccination for adolescents in the United States since 2006. Though recommended at a similar time to the routine recommendations for adolescent tetanus, diphtheria, and acellular pertussis vaccination (Tdap) and quadrivalent meningococcal vaccination (MCV4), HPV vaccine uptake has consistently lagged behind these other adolescent vaccines. The ACIP recommends HPV vaccination at 11-12 y, with vaccination starting at 9 ...
Source: Cancer Control - May 23, 2023 Category: Cancer & Oncology Authors: Robert A Bednarczyk Noel T Brewer Melissa B Gilkey Sherri Zorn Rebecca B Perkins Kristin Oliver Debbie Saslow Source Type: research
Analysis of prevailing pertussis strains from different regions in China after the application of acellular vaccines
Chin Med J (Engl). 2023 May 19. doi: 10.1097/CM9.0000000000002244. Online ahead of print.NO ABSTRACTPMID:37200036 | DOI:10.1097/CM9.0000000000002244
Source: Chinese Medical Journal - May 18, 2023 Category: General Medicine Authors: Yamin Liu Bei Jiang Yu Guo Yuan Gao Jing Qian Chunhua Qie Zhujun Shao Ying Li Qi Wu Source Type: research
Immunogenicity of the pentavalent DTwP-HB-Hib vaccine (Shan-5) used in the Thai Expanded Program on Immunization compared to the hexavalent DTaP-HB-Hib-IPV and DTwP-HB-Hib (Quinvaxem) vaccines administered to infants at 2, 4, 6 months of age
CONCLUSIONS: The immunogenicity of the HepB surface antigen in the EPI Shan-5 vaccine was similar to that achieved by the hexavalent vaccine, but was higher than that achieved by the Quinvaxem vaccine. The Shan-5 vaccine is highly immunogenic and generates robust antibody responses after primary immunization.PMID:37202270 | DOI:10.1016/j.vaccine.2023.05.014
Source: Vaccine - May 18, 2023 Category: Allergy & Immunology Authors: Nasamon Wanlapakorn Napa Pruetarat Nasiri Sarawanangkoor Kanchana Phanphanit Donchida Srimuan Thaksaporn Thatsanathorn Thanunrat Thongmee Nawarat Posuwan Yong Poovorawan Source Type: research
Analysis of prevailing pertussis strains from different regions in China after the application of acellular vaccines
Chin Med J (Engl). 2023 May 19. doi: 10.1097/CM9.0000000000002244. Online ahead of print.NO ABSTRACTPMID:37200036 | DOI:10.1097/CM9.0000000000002244
Source: Chinese Medical Journal - May 18, 2023 Category: General Medicine Authors: Yamin Liu Bei Jiang Yu Guo Yuan Gao Jing Qian Chunhua Qie Zhujun Shao Ying Li Qi Wu Source Type: research
